Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Mercury in vaccines from the Australian childhood immunization program schedule.

Austin DW, Shandley KA, Palombo EA.

J Toxicol Environ Health A. 2010;73(10):637-40. doi: 10.1080/15287391003613994.

PMID:
20391108
2.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
3.

[Mercury in vaccines].

Hessel L.

Bull Acad Natl Med. 2003;187(8):1501-10. Review. French.

PMID:
15146581
5.

Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.

Dórea JG.

Am J Perinatol. 2007 Aug;24(7):387-400. Epub 2007 Jun 12. Review.

PMID:
17564957
6.

Predicted mercury concentrations in hair from infant immunizations: cause for concern.

Redwood L, Bernard S, Brown D.

Neurotoxicology. 2001 Oct;22(5):691-7.

PMID:
11770890
7.

How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.

Posfay-Barbe KM, Heininger U, Aebi C, Desgrandchamps D, Vaudaux B, Siegrist CA.

Pediatrics. 2005 Nov;116(5):e623-33.

PMID:
16263976
8.

Recommendations regarding the use of vaccines that contain thimerosal as a preservative.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Nov 5;48(43):996-8.

9.

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

N Engl J Med. 2007 Sep 27;357(13):1281-92.

10.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
12.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.

Pediatrics. 2008 Feb;121(2):e208-14. doi: 10.1542/peds.2006-3363.

PMID:
18245396
13.

Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Jul 9;48(26):563-5.

14.

Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.

Marques RC, Dórea JG, Fonseca MF, Bastos WR, Malm O.

Eur J Pediatr. 2007 Sep;166(9):935-41. Epub 2007 Jan 20.

PMID:
17237965
15.

Changes in children hair-Hg concentrations during the first 5 years: maternal, environmental and iatrogenic modifying factors.

Marques RC, Dórea JG, Bastos WR, Malm O.

Regul Toxicol Pharmacol. 2007 Oct;49(1):17-24. Epub 2007 May 10.

PMID:
17566620
16.
17.

Thiomersal in vaccines: is removal warranted?

Clements CJ, Ball LK, Ball R, Pratt RD.

Drug Saf. 2001;24(8):567-74. Review.

PMID:
11480489
18.

Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.

Young HA, Geier DA, Geier MR.

J Neurol Sci. 2008 Aug 15;271(1-2):110-8. doi: 10.1016/j.jns.2008.04.002. Epub 2008 May 15.

PMID:
18482737
19.

Continuing increases in autism reported to California's developmental services system: mercury in retrograde.

Schechter R, Grether JK.

Arch Gen Psychiatry. 2008 Jan;65(1):19-24. doi: 10.1001/archgenpsychiatry.2007.1.

PMID:
18180424
20.

The evidence for the safety of thiomersal in newborn and infant vaccines.

Clements CJ.

Vaccine. 2004 May 7;22(15-16):1854-61. Review.

PMID:
15121295

Supplemental Content

Support Center